bioRxivCell Biology
Conformational specificity of opioid receptors is determined by subcellular location irrespective of agonist
Abstract
The prevailing model for the variety in drug responses is that they stabilize distinct active states of their G protein-coupled receptor (GPCR) targets, allowing coupling to different effectors. However, whether the same ligand can produce different GPCR active states based on the environment of receptors in cells is a fundamental unanswered question. Here we address this question using live cell imaging of conformational biosensors that read out distinct active conformations of the {delta}-opioid receptor (DOR), a physiologically relevant GPCR localized to Golgi and the surface in neurons. We show that, although Golgi and surface pools of DOR regulated cAMP, the two pools engaged distinct conformational biosensors in response to the same ligand. Further, DOR recruited arrestin on the plasma membrane but not the Golgi. Our results suggest that the same agonist drives different conformations of a GPCR at different locations, allowing receptor coupling to distinct effectors at different locations.
- organism: mouse
- assay: fluorescence / live-cell microscopy
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- approach: microscopy & imaging analysis
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Subcellular location defines GPCR signal transduction
A. Radoux-Mergault, L. Oberhauser, … M. Stoeber·bioRxiv·Dec 12, 2022
- A genetically encoded biosensor reveals location bias of opioid drug action
Miriam Stoeber, Damien Jullié, … Mark von Zastrow·NeuronPeer-reviewed·May 10, 2018
- Molecular insights into the μ-opioid receptorselective signaling
Xiaojing Cong, Damien Maurel, … Rémy Sounier·bioRxiv·Mar 22, 2021
- Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
- Opioid receptors reveal a discrete cellular mechanism of endosomal G protein activation
Nicole M. Fisher, Mark von Zastrow·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 22, 2025
- Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells
M. Stoeber, D. Jullie, … M. von Zastrow·bioRxiv·Dec 5, 2019